News tagged ‘BreastCancer’ clear
Kornelia Polyak, MD, PhD, and colleagues identified a network of growth-spurring genes that drive stem-like breast cancer cells enriched in triple-negative breast tumors.
Tags: BreastCancer, Genomics
- Breast cancer risk and prevention experts comment on new guidelines
suggesting women ages 40 to 49 do not need regular breast cancer
screenings.
Tags: BreastCancer
Erica Mayer, MD, MPH, is a breast cancer expert at Dana-Farber. She says there are at least five simple ways women can reduce their risk of getting the disease.
Tags: BreastCancer, Genetics, Prevention
- Using a novel three-part screening process, scientists at Dana-Farber
Cancer Institute have identified a gene that is made inappropriately in
about a third of all breast cancers. The discovery, reached in
collaboration with researchers at Brigham and Womens Hospital (BWH) and
the Broad Institute of Harvard and MIT, is reported in the June 15,
2007, issue of the journal Cell.
Tags: BasicResearch, BreastCancer
A new report showing that breast cancer patients treated with low doses of radiation therapy have a heightened risk of heart disease suggests that physicians need to work with patients before, during, and after treatment to minimize that risk.
Tags: BreastCancer, Radiation, Survivorship
- When a form of cancer that begins in the milk ducts of the breast
invades neighboring tissue to spread to other parts of the body, the
cause lies not in the tumor cells themselves but in a group of abnormal
surrounding cells that cause the walls of the duct to deteriorate like a
rusty pipe, according to a new study led by Dana-Farber Cancer
Institute researchers.
Tags: BasicResearch, BreastCancer
- The committee will help the CDC develop evidence-based approaches to advance the understanding and awareness of breast cancer among young women.
Tags: BreastCancer
In one of the largest breast cancer sequencing efforts to date, scientists from Dana-Farber and their colleagues have discovered surprising alterations in genes that were not previously associated with breast cancer.
Tags: BasicResearch, BreastCancer, Genomics
- Results of the study show greater efforts are needed to ensure that all
women receive the most effective breast cancer care, regardless of their
race or ethnicity.
Tags: BreastCancer, Disparities
Dana-Farber researchers have demonstrated a molecular strategy that they say could make a much larger variety of tumors treatable with PARP inhibitors, a promising new class of cancer drugs.
Tags: BreastCancer, OvarianCancer, GynecologicCancers
Showing 21-30 of 33 items